Press release
Global Antisense & RNAi Therapeutics Market to Reach $3.18 Billion by 2029, Growing at 13.1% CAGR
Antisense & RNAi Therapeutics
The escalating occurrence of coronary artery illnesses, neurodegenerative conditions, and infectious diseases is expected to increase the demand for antisense & RNAi therapeutics market. Gene suppression methods such as RNA interference and antisense oligonucleotides are employed to treat a range of neurodegenerative diseases by fixing faulty genes. For example, in January 2024, the American Heart Association, a US-based entity, noted in its report that the age-adjusted death toll from cardiovascular ailments rose to 233.3 per 100,000, indicating a 4.0% surge from the preceding year. Consequently, the mounting prevalence of numerous neurodegenerative and infectious diseases is anticipated to propel the expansion of the antisense & RNAi therapeutics market.
Get Your Antisense & RNAi Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/report/antisense-and-rnai-therapeutics-global-market-report
What growth opportunities are expected to drive the antisense & rnai therapeutics market's CAGR through 2034?
In the last few years, the antisense & RNAi therapeutics market has experienced a significant surge in size. The market is projected to expand from $1.75 billion in 2024 to $1.94 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.2%. Factors contributing to the growth during the historic period include an increase in funding, advancements in technologies, a rise in healthcare spending, a fast-growing elderly population, and economic growth in up-and-coming markets.
The market for antisense & RNAi therapeutics is predicted to experience a swift expansion in the coming years, with an expected value of $3.18 billion by 2029, developing at a compound annual growth rate (CAGR) of 13.1%. This growth in the projected period can be traced back to the enhanced access to healthcare, increased cancer rates, and the growing need for antisense and RNAi therapeutic solutions stemming from COVID-19. The forecast period is predominantly characterized by concentrated research and development into RNA therapies for rare diseases, employment of nanoparticles, progress in creating better antisense and RNAi treatments, and strategic alliances with various firms for the sake of product innovation and revenue growth.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3389&type=smp
What are the emerging trends shaping the future of the antisense & rnai therapeutics market?
Key players in the antisense and RNAi therapeutics market are employing strategic moves such as alliances and partnerships to remain competitive. The strategy of strategic collaboration involves multiple corporations working towards a shared goal or objective. For example, in January 2023, US-based Orbit Discovery Limited, providing peptide discovery services, forged a partnership with SanegeneBio Inc., a UK-based firm engaged in the invention of novel RNAi-based medicines. The partnership's aim was to identify tissue-specific delivery of RNA therapeutics for effective gene knockdown and to build an array of advanced RNAi therapeutics. The partnership includes hit identification and cell-based internalization studies. Sanegene has the option to take the project further by developing the hits produced from the screening process, using Orbit's exclusive technology for quick peptide lead discovery. Orbit Discovery's distinctive peptide display engine enables the screening of extensive peptide libraries, facilitating the swift discovery of appropriate peptide leads, based on affinity and functional screens.
Which growth-oriented segments of the antisense & rnai therapeutics market are leading the industry's development?
The antisense & RNAi therapeutics market covered in this report is segmented -
1) By Technology: RNA Interference, Antisense RNA
2) By Route Of Administration: Intravenous Injections, Intra-dermal Injections, Other Delivery Methods
3) By Indication: Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Neurological Disorders, Infectious Diseases, Other Indications
Subsegments:
1) By RNA Interference (RNAi): Small Interfering RNA (siRNA), Short Hairpin RNA (shRNA), Dicer-substrate siRNA, MicroRNA (miRNA) Based Therapeutics
2) By Antisense RNA: Antisense Oligonucleotides (ASOs), Morpholino Oligomers, Locked Nucleic Acids (LNAs), Gapmer Antisense Oligonucleotides
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3389
What regions are leading the charge in the antisense & rnai therapeutics market?
North America was the largest region in the antisense & RNAi therapeutics market in 2024. The regions covered in the antisense & RNAi therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What companies are at the forefront of innovation in the antisense & rnai therapeutics market?
Major companies operating in the antisense & RNAi therapeutics market include Biogen Inc., Ionis Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Moderna Inc., Sanofi S.A., Dicerna Pharmaceuticals Inc., Arbutus Biopharma Corporation, Acuitas Therapeutics, Adhera Therapeutics Inc., EdiGene Inc., Sirnaomics Inc., Suzhou Ribo Life Science Co. Ltd, Biocon Limited, Quark Pharmaceuticals, GlaxoSmithKline Plc, Shanghai Junshi Biosciences Co. Ltd., AstraZeneca, Benitec Biopharma Limited, Silence Therapeutics, Dynacure, CN Bio Innovations, Sarepta Therapeutics, Mallinckrodt, Regeneron Pharmaceuticals Inc., Alcyone Lifesciences Inc., Bio-Path Holdings Inc, Calando Pharmaceuticals, Enzon Pharmaceuticals Inc, Celnova Pharma, Pfizer Inc., Taiba Pharma, Gen Ilaç ve Saglik Ürünleri A.S., Egypt Otsuka Pharmaceutical
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=3389&type=smp
What Is Covered In The Antisense & RNAi Therapeutics Global Market Report?
•Market Size Forecast: Examine the antisense & rnai therapeutics market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the antisense & rnai therapeutics market for a structured understanding.
•Key Players Overview: Analyze major players in the antisense & rnai therapeutics market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the antisense & rnai therapeutics market.
•Segment Contributions: Evaluate how different segments drive overall growth in the antisense & rnai therapeutics market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the antisense & rnai therapeutics market.
•Industry Challenges: Identify potential risks and obstacles affecting the antisense & rnai therapeutics market.
•Competitive Landscape: Review strategic developments in the antisense & rnai therapeutics market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Antisense & RNAi Therapeutics Market to Reach $3.18 Billion by 2029, Growing at 13.1% CAGR here
News-ID: 3898867 • Views: …
More Releases from The Business Research Company
Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the M …
The meal replacement market is gaining significant momentum as consumer preferences shift toward convenient and health-focused nutrition solutions. With rising awareness about preventive healthcare and personalized diets, this sector is set for considerable expansion. Let's explore how the market size is expected to evolve, who the key players are, emerging trends, and the main segments driving this growth.
Projected Growth Trajectory of the Meal Replacement Market Size
The meal replacement…
Leading Companies Reinforcing Their Presence in the Malted Barley Market
The malted barley industry is positioned for steady expansion as demand grows across various sectors. With increasing interest from craft brewers and functional food producers, this market is set to experience meaningful growth driven by innovation and sustainability efforts. Let's dive into the current market size, key players shaping the industry, trends influencing its trajectory, and detailed segment insights.
Projected Market Size and Growth Outlook of the Malted Barley Market …
Future Perspective: Key Trends Shaping the Low-calorie Food Market up to 2030
The low-calorie food market is poised for significant expansion as consumer preferences shift toward healthier eating habits and more personalized nutrition options. Advances in product innovation and supportive regulatory frameworks are expected to drive rapid growth over the coming years. Here's an overview of the market size, key players, emerging trends, and segmentation shaping this evolving industry.
Projected Expansion of the Low-calorie Food Market Size Through 2030
The low-calorie food…
Competitive Landscape: Leading Companies and New Entrants in the Liquid Nutritio …
The liquid nutritional supplement sector is on the rise, driven by evolving consumer preferences and innovations in health and wellness. With growing awareness about personalized nutrition and preventive healthcare, this market is set to witness substantial growth over the coming years. Let's explore the market's projected size, major players, emerging trends, and key segments shaping this dynamic industry.
Projected Market Value and Growth Trajectory of the Liquid Nutritional Supplement Market …
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
